• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

OLFM2 和 OLFM4 在肠-肝轴中的新见解及其在非酒精性脂肪性肝病中的潜在作用。

New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease.

机构信息

Grup de Recerca GEMMAIR (AGAUR)-Medicina Aplicada, Departament de Medicina i Cirurgia, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), 43007 Tarragona, Spain.

Servei de Cirurgia General i de l'Aparell Digestiu, Hospital Universitari de Tarragona Joan XXIII, Universitat Rovira i Virgili (URV), Institut d'Investigació Sanitària Pere Virgili (IISPV), Mallafré Guasch, 4, 43007 Tarragona, Spain.

出版信息

Int J Mol Sci. 2022 Jul 4;23(13):7442. doi: 10.3390/ijms23137442.

DOI:10.3390/ijms23137442
PMID:35806447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9267292/
Abstract

Olfactomedins (OLFMs) are a family of glycoproteins that play a relevant role in embryonic development and in some pathological processes. Although OLFM2 is involved in the regulation of the energy metabolism and OLFM4 is an important player in inflammation, innate immunity and cancer, the role of OLFMs in NAFLD-related intestinal dysbiosis remains unknown. In this study, we analysed the hepatic mRNA expression of and the jejunal expression of in a well-established cohort of women with morbid obesity (MO), classified according to their hepatic histology into normal liver ( = 27), simple steatosis ( = 26) and nonalcoholic steatohepatitis (NASH, = 16). Our results showed that hepatic mRNA was higher in NASH, in advanced degrees of steatosis and in the presence of lobular inflammation. Additionally, we obtained positive correlations between hepatic and glucose, cholesterol, trimethylamine N-oxide and deoxycholic acid levels and hepatic fatty acid synthase, and negative associations with weight and jejunal Toll-like receptors () and expression. Regarding jejunal , we observed positive correlations with circulating interleukin (IL)-8, IL-10, IL-17 and jejunal . In conclusion, OLFM2 in the liver seems to play a relevant role in NAFLD progression, while OLFM4 in the jejunum could be involved in gut dysbiosis-related inflammatory events.

摘要

嗅觉素(OLFMs)是一类糖蛋白,在胚胎发育和某些病理过程中发挥重要作用。虽然 OLFM2 参与调节能量代谢,OLFM4 是炎症、先天免疫和癌症的重要参与者,但 OLFMs 在与 NAFLD 相关的肠道菌群失调中的作用尚不清楚。在这项研究中,我们分析了患有病态肥胖(MO)的女性中一个成熟队列的肝脏 mRNA 表达和空肠表达。这些女性根据其肝组织学分为正常肝脏(=27)、单纯性脂肪变性(=26)和非酒精性脂肪性肝炎(NASH,=16)。我们的结果表明,NASH 组、脂肪变性程度较高组和存在肝小叶炎症组的肝脏中 mRNA 水平较高。此外,我们还发现肝脏与葡萄糖、胆固醇、三甲胺 N-氧化物和脱氧胆酸水平之间存在正相关,与体重和空肠 Toll 样受体(TLRs)和表达之间存在负相关。关于空肠,我们观察到与循环白细胞介素(IL)-8、IL-10、IL-17 和空肠呈正相关。总之,肝脏中的 OLFM2 似乎在 NAFLD 进展中发挥重要作用,而空肠中的 OLFM4 可能参与与肠道菌群失调相关的炎症事件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d24c/9267292/1baa0c53b4ec/ijms-23-07442-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d24c/9267292/93db9c90c497/ijms-23-07442-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d24c/9267292/aa715e79810b/ijms-23-07442-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d24c/9267292/36dd1293ab19/ijms-23-07442-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d24c/9267292/3b6648e86cb6/ijms-23-07442-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d24c/9267292/1baa0c53b4ec/ijms-23-07442-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d24c/9267292/93db9c90c497/ijms-23-07442-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d24c/9267292/aa715e79810b/ijms-23-07442-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d24c/9267292/36dd1293ab19/ijms-23-07442-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d24c/9267292/3b6648e86cb6/ijms-23-07442-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d24c/9267292/1baa0c53b4ec/ijms-23-07442-g005.jpg

相似文献

1
New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease.OLFM2 和 OLFM4 在肠-肝轴中的新见解及其在非酒精性脂肪性肝病中的潜在作用。
Int J Mol Sci. 2022 Jul 4;23(13):7442. doi: 10.3390/ijms23137442.
2
The Role of Olfactomedin 2 in the Adipose Tissue-Liver Axis and Its Implication in Obesity-Associated Nonalcoholic Fatty Liver Disease.嗅鞘蛋白 2 在脂肪组织-肝脏轴中的作用及其在肥胖相关非酒精性脂肪性肝病中的意义。
Int J Mol Sci. 2023 Mar 9;24(6):5221. doi: 10.3390/ijms24065221.
3
The Potential Protective Role of RUNX1 in Nonalcoholic Fatty Liver Disease.RUNX1在非酒精性脂肪性肝病中的潜在保护作用
Int J Mol Sci. 2021 May 15;22(10):5239. doi: 10.3390/ijms22105239.
4
Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis.白细胞介素-8 循环水平与病态肥胖和非酒精性脂肪性肝炎妇女肝组织中 TLR2 表达的关系。
Int J Mol Sci. 2020 Jun 11;21(11):4189. doi: 10.3390/ijms21114189.
5
Circulating microbiota-derived metabolites: a "liquid biopsy?循环微生物衍生代谢物:一种“液体活检”?
Int J Obes (Lond). 2020 Apr;44(4):875-885. doi: 10.1038/s41366-019-0430-0. Epub 2019 Aug 6.
6
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.与健康正常体重个体相比,不同程度非酒精性脂肪性肝病患者的肝转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G462-G472. doi: 10.1152/ajpgi.00358.2018. Epub 2019 Jan 17.
7
Increased Hepatic mRNA and ATG7 Protein Expression in Nonalcoholic Steatohepatitis Associated with Obesity.肥胖相关非酒精性脂肪性肝炎中肝组织 mRNA 和 ATG7 蛋白表达增加。
Int J Mol Sci. 2023 Jan 10;24(2):1324. doi: 10.3390/ijms24021324.
8
Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease.非酒精性脂肪性肝炎的发病机制:营养过剩的代谢并发症如何导致脂毒性和促炎脂肪性肝病。
Adv Exp Med Biol. 2018;1061:19-44. doi: 10.1007/978-981-10-8684-7_3.
9
Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity.非酒精性脂肪性肝病相关肥胖中分泌型卷曲相关蛋白 5 的失调。
Int J Mol Sci. 2021 Jun 27;22(13):6895. doi: 10.3390/ijms22136895.
10
Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.肠道微生物群和Toll样受体在非酒精性脂肪性肝病中的作用。
World J Gastroenterol. 2014 Jun 21;20(23):7381-91. doi: 10.3748/wjg.v20.i23.7381.

引用本文的文献

1
Single-variant genome-wide association study and regional heritability mapping of protein efficiency and performance traits in Large White pigs.大白猪蛋白质效率和生产性能性状的单变异全基因组关联研究及区域遗传力定位
Genet Sel Evol. 2025 Aug 14;57(1):45. doi: 10.1186/s12711-025-00993-z.
2
Interactions between microbiota and uterine corpus endometrial cancer: A bioinformatic investigation of potential immunotherapy.微生物群与子宫体子宫内膜癌的相互作用:潜在免疫治疗的生物信息学研究。
PLoS One. 2024 Oct 30;19(10):e0312590. doi: 10.1371/journal.pone.0312590. eCollection 2024.
3
Metabolic underpinnings of cancer-related fatigue.

本文引用的文献

1
The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease.营养对健康和疾病状态下肠道通透性及微生物群的影响
Front Nutr. 2022 Apr 25;9:718710. doi: 10.3389/fnut.2022.718710. eCollection 2022.
2
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver.代谢相关脂肪性肝病(MAFLD):一种超越肝脏的多系统疾病。
J Clin Transl Hepatol. 2022 Apr 28;10(2):329-338. doi: 10.14218/JCTH.2021.00178. Epub 2021 Oct 19.
3
Lipid alterations in chronic liver disease and liver cancer.
癌症相关疲劳的代谢基础。
Am J Physiol Endocrinol Metab. 2024 Mar 1;326(3):E290-E307. doi: 10.1152/ajpendo.00378.2023. Epub 2024 Jan 31.
4
Obesity wars: may the smell be with you.肥胖战争:愿气味与你同在。
Am J Physiol Endocrinol Metab. 2023 Jun 1;324(6):E569-E576. doi: 10.1152/ajpendo.00040.2023. Epub 2023 May 11.
5
The Role of Olfactomedin 2 in the Adipose Tissue-Liver Axis and Its Implication in Obesity-Associated Nonalcoholic Fatty Liver Disease.嗅鞘蛋白 2 在脂肪组织-肝脏轴中的作用及其在肥胖相关非酒精性脂肪性肝病中的意义。
Int J Mol Sci. 2023 Mar 9;24(6):5221. doi: 10.3390/ijms24065221.
慢性肝病和肝癌中的脂质改变。
JHEP Rep. 2022 Mar 26;4(6):100479. doi: 10.1016/j.jhepr.2022.100479. eCollection 2022 Jun.
4
Olfactomedin 2 deficiency protects against diet-induced obesity.嗅鞘蛋白 2 缺乏可预防饮食诱导的肥胖。
Metabolism. 2022 Apr;129:155122. doi: 10.1016/j.metabol.2021.155122. Epub 2022 Jan 11.
5
The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease.Notch信号通路在非酒精性脂肪性肝病中的作用
Front Mol Biosci. 2021 Nov 24;8:792667. doi: 10.3389/fmolb.2021.792667. eCollection 2021.
6
New targets for NAFLD.非酒精性脂肪性肝病的新靶点
JHEP Rep. 2021 Aug 8;3(6):100346. doi: 10.1016/j.jhepr.2021.100346. eCollection 2021 Dec.
7
Pathology of non-alcoholic fatty liver disease.非酒精性脂肪性肝病的病理学。
Pathologica. 2021 Jun;113(3):194-202. doi: 10.32074/1591-951X-242.
8
Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity.非酒精性脂肪性肝病相关肥胖中分泌型卷曲相关蛋白 5 的失调。
Int J Mol Sci. 2021 Jun 27;22(13):6895. doi: 10.3390/ijms22136895.
9
NF-κB p65 regulates hepatic lipogenesis by promoting nuclear entry of ChREBP in response to a high carbohydrate diet.NF-κB p65 通过促进 ChREBP 入核来调节肝内脂质生成,以响应高碳水化合物饮食。
J Biol Chem. 2021 Jan-Jun;296:100714. doi: 10.1016/j.jbc.2021.100714. Epub 2021 Apr 27.
10
Toll-like receptor 5-mediated signaling enhances liver regeneration in mice.Toll样受体5介导的信号传导增强小鼠肝脏再生。
Mil Med Res. 2021 Feb 23;8(1):16. doi: 10.1186/s40779-021-00309-4.